Companies / California / Oncotelic Therapeutics

· rebuilt nightly from public records

Signal Sheet

Selling to Oncotelic Therapeutics? Who to reach and why now

Aguora Hills, California is home to Oncotelic Therapeutics, a publicly listed pharmaceutical preparations company. It raised $712K in Jul 2026 and its filings name 6 officers. Everything below links to the record it came from.

Listed company · Pharmaceutical Preparations · California

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerVuong TrieuSEC filing, Jul 2026Named officer in the filing; part of the buying group
Executive OfficerAnthony MaidaSEC filing, Jul 2026Named officer in the filing; part of the buying group
Executive OfficerShah AmitSEC filing, Jul 2026Named officer in the filing; part of the buying group
Executive OfficerSeymour FeinSEC filing, Jul 2026Named officer in the filing; part of the buying group
Executive OfficerSaran SaundSEC filing, Jul 2026Named officer in the filing; part of the buying group
Chief Technology OfficerSteven KingSEC filing, Jul 2026Technology and tooling decisions
For sellersWhy Oncotelic Therapeutics is worth a call this quarterBuy Window: watching
Aug 2026Aug 2026

Corporate event

Signed a material agreement

Corporate event
$712K

Raised

Equity raise reported to the SEC, Jul 2026. Money arrives before the spending plan does.

Capital
$987K7 months

Back-to-back raises

2 equity raises in 7 months. Repeat funding is a company buying for growth, not maintenance.

Pattern
Track Oncotelic Therapeutics with a free trial →Get the next signal the day it is filed or posted.
Email me the next Oncotelic Therapeutics signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Aug 3, 2026Signed a material agreementCorporate eventSEC filing
Jul 10, 2026Raised $712K in equity from 33 investorsCapitalSEC filing
Dec 4, 2025Raised $275K in equity from 4 investorsCapitalSEC filing

Reach Oncotelic Therapeutics with emails that land

Lakewave finds the right people at Oncotelic Therapeutics, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on Oncotelic Therapeutics with a free trial →

About Oncotelic Therapeutics

HeadquartersAguora Hills, California, per the filing address
Industry groupPharmaceutical Preparations
OwnershipListed company
Raise history$275K (Dec 2025) · $712K (Jul 2026)
Lakewave Rising1 · 2 kinds of evidence · rank in California after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Mirum Pharmaceuticals · 35Neonc Technologies · 35Abvc Biopharma · 29Adial Pharmaceuticals · 28Maplight Therapeutics · 26Latigo Biotherapeutics · 19See all 6 with a free trial →

Questions people ask

Did Oncotelic Therapeutics raise funding in 2026?

Yes. Oncotelic Therapeutics reported a $712K equity raise to the SEC on Jul 10, 2026 with 33 investors.

Who runs Oncotelic Therapeutics?

The company's SEC filing, Jul 2026 names Vuong Trieu (Executive Officer) among its officers.

Where is Oncotelic Therapeutics headquartered?

Aguora Hills, California, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.